Together, these data show that the PKD inhibitor CID755673 enhanced cardiac systolic and diastolic function in diabetic cardiomyopathy in association with reduced heart size, but with only minor alterations in LV internal structural dimensions. The gene discussed is PRKD1; the disease is diabetic cardiomyopathy.